| Gene . | Sequences of primers . | Product length . | NCBI Reference Sequence . |
|---|---|---|---|
| β-actin | F 5′- CATCCGTAAAGACCTCTATGCCAAC- 3′ | 171 bp | NM_007393.5 |
| R 5′- ATGGAGCCACCGATCCACA-3′ | |||
| Tlr2 | F 5′- CGTTGTTCCCTGTGTTGCT-3′ | 119 bp | NM_011905.3 |
| R 5′- AAAGTGGTTGTCGCCTGCT-3′ | |||
| Msr1 | F 5′- CCAAGTCCTTGCAGAGTCTG-3′ | 237 bp | NM_ 001113326.1 |
| R 5′- GTCTGAGGTCGTTGGTGATG -3′ | |||
| Mrc1 | F 5′- GTCTGAGTGTACGCAGTGGTTGG-3′ | 85 bp | NM_ 008625.2 |
| R 5′- TCTGATGATGGACTTCCTGGTAGCC-3′ | |||
| Ctsl | F 5′- GACCGGGACAACCACTGTG- 3′ | 64 bp | NM_ 009984.4 |
| R 5′- CTACCCATCAATTCACGAC-3′ |
| Gene . | Sequences of primers . | Product length . | NCBI Reference Sequence . |
|---|---|---|---|
| β-actin | F 5′- CATCCGTAAAGACCTCTATGCCAAC- 3′ | 171 bp | NM_007393.5 |
| R 5′- ATGGAGCCACCGATCCACA-3′ | |||
| Tlr2 | F 5′- CGTTGTTCCCTGTGTTGCT-3′ | 119 bp | NM_011905.3 |
| R 5′- AAAGTGGTTGTCGCCTGCT-3′ | |||
| Msr1 | F 5′- CCAAGTCCTTGCAGAGTCTG-3′ | 237 bp | NM_ 001113326.1 |
| R 5′- GTCTGAGGTCGTTGGTGATG -3′ | |||
| Mrc1 | F 5′- GTCTGAGTGTACGCAGTGGTTGG-3′ | 85 bp | NM_ 008625.2 |
| R 5′- TCTGATGATGGACTTCCTGGTAGCC-3′ | |||
| Ctsl | F 5′- GACCGGGACAACCACTGTG- 3′ | 64 bp | NM_ 009984.4 |
| R 5′- CTACCCATCAATTCACGAC-3′ |
F, forward; R, reverse.
| Gene . | Sequences of primers . | Product length . | NCBI Reference Sequence . |
|---|---|---|---|
| β-actin | F 5′- CATCCGTAAAGACCTCTATGCCAAC- 3′ | 171 bp | NM_007393.5 |
| R 5′- ATGGAGCCACCGATCCACA-3′ | |||
| Tlr2 | F 5′- CGTTGTTCCCTGTGTTGCT-3′ | 119 bp | NM_011905.3 |
| R 5′- AAAGTGGTTGTCGCCTGCT-3′ | |||
| Msr1 | F 5′- CCAAGTCCTTGCAGAGTCTG-3′ | 237 bp | NM_ 001113326.1 |
| R 5′- GTCTGAGGTCGTTGGTGATG -3′ | |||
| Mrc1 | F 5′- GTCTGAGTGTACGCAGTGGTTGG-3′ | 85 bp | NM_ 008625.2 |
| R 5′- TCTGATGATGGACTTCCTGGTAGCC-3′ | |||
| Ctsl | F 5′- GACCGGGACAACCACTGTG- 3′ | 64 bp | NM_ 009984.4 |
| R 5′- CTACCCATCAATTCACGAC-3′ |
| Gene . | Sequences of primers . | Product length . | NCBI Reference Sequence . |
|---|---|---|---|
| β-actin | F 5′- CATCCGTAAAGACCTCTATGCCAAC- 3′ | 171 bp | NM_007393.5 |
| R 5′- ATGGAGCCACCGATCCACA-3′ | |||
| Tlr2 | F 5′- CGTTGTTCCCTGTGTTGCT-3′ | 119 bp | NM_011905.3 |
| R 5′- AAAGTGGTTGTCGCCTGCT-3′ | |||
| Msr1 | F 5′- CCAAGTCCTTGCAGAGTCTG-3′ | 237 bp | NM_ 001113326.1 |
| R 5′- GTCTGAGGTCGTTGGTGATG -3′ | |||
| Mrc1 | F 5′- GTCTGAGTGTACGCAGTGGTTGG-3′ | 85 bp | NM_ 008625.2 |
| R 5′- TCTGATGATGGACTTCCTGGTAGCC-3′ | |||
| Ctsl | F 5′- GACCGGGACAACCACTGTG- 3′ | 64 bp | NM_ 009984.4 |
| R 5′- CTACCCATCAATTCACGAC-3′ |
F, forward; R, reverse.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
